D
Teva Pharmaceutical Industries Limited
TEVJF
$14.80
-$0.07-0.47%
D
Sell
1/7/2025Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 1/7/2025 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 572.82% from $103M to $693M, earnings per share increased from -$0.75 to -$0.39, and EBIT increased 22.89% from $817M to $1B.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 1/7/2025 due to a significant increase in the growth index, volatility index and total return index. Operating cash flow increased 572.82% from $103M to $693M, earnings per share increased from -$0.75 to -$0.39, and EBIT increased 22.89% from $817M to $1B.
D
Sell
5/22/2023Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/22/2023 due to a substantial decline in the efficiency index, volatility index and growth index. Operating cash flow declined 114.9% from $973M to -$145M, EBIT declined 22.07% from $639M to $498M, and total revenue declined 5.74% from $3.88B to $3.66B.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/22/2023 due to a substantial decline in the efficiency index, volatility index and growth index. Operating cash flow declined 114.9% from $973M to -$145M, EBIT declined 22.07% from $639M to $498M, and total revenue declined 5.74% from $3.88B to $3.66B.
D
Sell
11/7/2022Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 11/7/2022 due to a significant decline in the growth index and solvency index. The quick ratio declined from 0.59 to 0.52, and total revenue declined 5.04% from $3.79B to $3.6B.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 11/7/2022 due to a significant decline in the growth index and solvency index. The quick ratio declined from 0.59 to 0.52, and total revenue declined 5.04% from $3.79B to $3.6B.
D
Sell
7/28/2022Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 7/28/2022 due to a significant increase in the growth index, volatility index and valuation index. Operating cash flow increased 351.02% from -$49M to $123M, earnings per share increased from -$0.8627 to -$0.21, and total revenue increased 3.41% from $3.66B to $3.79B.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 7/28/2022 due to a significant increase in the growth index, volatility index and valuation index. Operating cash flow increased 351.02% from -$49M to $123M, earnings per share increased from -$0.8627 to -$0.21, and total revenue increased 3.41% from $3.66B to $3.79B.
D
Sell
5/31/2022Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index and total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index and total return index.
D
Sell
5/13/2022Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/13/2022 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 500.63% from -$159M to -$955M, earnings per share declined from -$0.1442 to -$0.8627, and operating cash flow declined 110.75% from $456M to -$49M.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/13/2022 due to a significant decline in the valuation index, efficiency index and growth index. Net income declined 500.63% from -$159M to -$955M, earnings per share declined from -$0.1442 to -$0.8627, and operating cash flow declined 110.75% from $456M to -$49M.
D
Sell
1/28/2022Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 1/28/2022 due to a decline in the total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 1/28/2022 due to a decline in the total return index.
D
Sell
1/13/2022Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 1/13/2022 due to an increase in the volatility index and total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 1/13/2022 due to an increase in the volatility index and total return index.
D
Sell
12/29/2021Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 12/29/2021 due to a decline in the total return index and volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 12/29/2021 due to a decline in the total return index and volatility index.
D
Sell
11/3/2021Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the valuation index, total return index and growth index. Operating cash flow increased 142.66% from $218M to $529M, and earnings per share increased from $0.1877 to $0.26.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D+ from D on 11/3/2021 due to a significant increase in the valuation index, total return index and growth index. Operating cash flow increased 142.66% from $218M to $529M, and earnings per share increased from $0.1877 to $0.26.
D
Sell
11/12/2019Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 11/12/2019 due to an increase in the growth index, volatility index and valuation index. Operating cash flow increased 243.17% from -$227M to $325M, earnings per share increased from -$0.631 to -$0.29, and EBIT increased 2.65% from $679M to $697M.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 11/12/2019 due to an increase in the growth index, volatility index and valuation index. Operating cash flow increased 243.17% from -$227M to $325M, earnings per share increased from -$0.631 to -$0.29, and EBIT increased 2.65% from $679M to $697M.
D
Sell
5/22/2019Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/22/2019 due to a decline in the volatility index and total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 5/22/2019 due to a decline in the volatility index and total return index.
D
Sell
5/7/2019Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 5/7/2019 due to an increase in the growth index, valuation index and volatility index. Earnings per share increased from -$2.8516 to -$0.1.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to D from D- on 5/7/2019 due to an increase in the growth index, valuation index and volatility index. Earnings per share increased from -$2.8516 to -$0.1.
D
Sell
4/23/2019Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 4/23/2019 due to a large decline in the efficiency index, growth index and dividend index. Net income declined 1,287.5% from -$208M to -$2.89B, earnings per share declined from -$0.27 to -$2.8516, and operating cash flow declined 12.83% from $421M to $367M.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D- from D on 4/23/2019 due to a large decline in the efficiency index, growth index and dividend index. Net income declined 1,287.5% from -$208M to -$2.89B, earnings per share declined from -$0.27 to -$2.8516, and operating cash flow declined 12.83% from $421M to $367M.
D
Sell
8/4/2017Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 8/4/2017 due to a major decline in the efficiency index, volatility index and solvency index. Net income declined 1,025.58% from $645M to -$5.97B, debt to equity increased from 1.14 to 1.44, and total capital declined 8.13% from $70.38B to $64.66B.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D from D+ on 8/4/2017 due to a major decline in the efficiency index, volatility index and solvency index. Net income declined 1,025.58% from $645M to -$5.97B, debt to equity increased from 1.14 to 1.44, and total capital declined 8.13% from $70.38B to $64.66B.
D
Sell
4/3/2017Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D+ from C- on 4/3/2017 due to a noticeable decline in the total return index and volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D+ from C- on 4/3/2017 due to a noticeable decline in the total return index and volatility index.
C
Hold
2/17/2017Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 2/17/2017 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.35 to -$1.0227, net income declined 336.17% from $412M to -$973M, and total capital declined 4.18% from $73.88B to $70.79B.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 2/17/2017 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.35 to -$1.0227, net income declined 336.17% from $412M to -$973M, and total capital declined 4.18% from $73.88B to $70.79B.
C
Hold
2/16/2017Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to C from C- on 2/16/2017 due to an increase in the valuation index and dividend index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to C from C- on 2/16/2017 due to an increase in the valuation index and dividend index.
C
Hold
2/1/2017Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 2/1/2017 due to a large decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.42 to 1.17, and the quick ratio declined from 0.86 to 0.5.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 2/1/2017 due to a large decline in the volatility index, total return index and solvency index. Debt to equity increased from 0.42 to 1.17, and the quick ratio declined from 0.86 to 0.5.
C
Hold
9/8/2016Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to C from D+ on 9/8/2016 due to an increase in the efficiency index and dividend index. Total capital increased 5.5% from $40.8B to $43.05B.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to C from D+ on 9/8/2016 due to an increase in the efficiency index and dividend index. Total capital increased 5.5% from $40.8B to $43.05B.
D
Sell
5/2/2016Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D+ from C- on 5/2/2016 due to a noticeable decline in the volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to D+ from C- on 5/2/2016 due to a noticeable decline in the volatility index.
C
Hold
4/1/2016Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 4/1/2016 due to a decline in the total return index, valuation index and efficiency index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 4/1/2016 due to a decline in the total return index, valuation index and efficiency index.
C
Hold
2/1/2016Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 2/1/2016 due to a noticeable decline in the volatility index and total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 2/1/2016 due to a noticeable decline in the volatility index and total return index.
B
Buy
11/3/2015Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B- from C on 11/3/2015 due to an increase in the volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B- from C on 11/3/2015 due to an increase in the volatility index.
C
Hold
10/1/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 10/1/2015 due to a decline in the total return index and volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 10/1/2015 due to a decline in the total return index and volatility index.
B
Buy
9/1/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 9/1/2015 due to a decline in the solvency index and volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 9/1/2015 due to a decline in the solvency index and volatility index.
B
Buy
7/31/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B from B+ on 7/31/2015 due to a decline in the valuation index, volatility index and efficiency index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B from B+ on 7/31/2015 due to a decline in the valuation index, volatility index and efficiency index.
B
Buy
7/13/2015Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B+ from C- on 7/13/2015 due to an increase in the total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B+ from C- on 7/13/2015 due to an increase in the total return index.
C
Hold
7/1/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 7/1/2015 due to a decline in the total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C- from C on 7/1/2015 due to a decline in the total return index.
C
Hold
5/1/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 5/1/2015 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from $0.8004 to $0.52, operating cash flow declined 22.72% from $1.75B to $1.35B, and total revenue declined 3.6% from $5.17B to $4.98B.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 5/1/2015 due to a large decline in the growth index, total return index and volatility index. Earnings per share declined from $0.8004 to $0.52, operating cash flow declined 22.72% from $1.75B to $1.35B, and total revenue declined 3.6% from $5.17B to $4.98B.
B
Buy
4/1/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 04/01/2015.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 04/01/2015.
B
Buy
3/9/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B from A- on 3/9/2015 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from $1.02 to $0.8004.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B from A- on 3/9/2015 due to a decline in the growth index, solvency index and volatility index. Earnings per share declined from $1.02 to $0.8004.
A
Buy
2/10/2015Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to A- from C on 2/10/2015 due to an increase in the volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to A- from C on 2/10/2015 due to an increase in the volatility index.
C
Hold
1/2/2015Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 01/02/2015.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 01/02/2015.
B
Buy
12/1/2014Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 12/1/2014 due to a decline in the volatility index and dividend index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 12/1/2014 due to a decline in the volatility index and dividend index.
B
Buy
10/6/2014Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B from C on 10/06/2014.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B from C on 10/06/2014.
C
Hold
9/2/2014Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 9/2/2014 due to a decline in the volatility index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 9/2/2014 due to a decline in the volatility index.
B
Buy
7/17/2014Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 7/17/2014 due to a noticeable decline in the volatility index, valuation index and dividend index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to B- from B on 7/17/2014 due to a noticeable decline in the volatility index, valuation index and dividend index.
B
Buy
6/16/2014Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B from C on 6/16/2014 due to an increase in the volatility index and total return index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B from C on 6/16/2014 due to an increase in the volatility index and total return index.
C
Hold
6/2/2014Downgrade
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 6/2/2014 due to a decline in the total return index and dividend index.
Teva Pharmaceutical Industries Limited (TEVJF) was downgraded to C from B- on 6/2/2014 due to a decline in the total return index and dividend index.
B
Buy
3/26/2014Upgraded
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B- from C+ on 3/26/2014 due to a large increase in the total return index, volatility index and efficiency index.
Teva Pharmaceutical Industries Limited (TEVJF) was upgraded to B- from C+ on 3/26/2014 due to a large increase in the total return index, volatility index and efficiency index.
OTC PK
03/07/2025 1:17PM Eastern
Quotes delayed
